surmount-1 tirzepatide trial weight loss non-diabetic obesity For the first time, and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b Comparative Efficacy and Safety of

Previous studies have suggested a correlation between insulin resistance and hair loss in some patients, although definitive mechanistic relationships remain poorly understood

This also extends to optimising the patient experience to create competitive differentiation and ensure adherence and engagement with patients and clinical stakeholders

However, for use of PT-141 in the context of sexual function, both routes have demonstrated effectiveness in clinical settings

Real-World Experience: Outside controlled studies, patients frequently notice subtle early changes such as reduced energy or tighter clothing if old habits return, reinforcing the importance of long-term support